{"id":14944,"date":"2023-10-17T08:25:00","date_gmt":"2023-10-17T08:25:00","guid":{"rendered":"https:\/\/www.intelerad.com\/en\/?post_type=press-release&p=14944"},"modified":"2024-08-30T10:27:07","modified_gmt":"2024-08-30T10:27:07","slug":"densitas-and-intelerad-forge-strategic-partnership-to-advance-breast-cancer-screening-with-innovative-ai-technology","status":"publish","type":"press-release","link":"https:\/\/www.intelerad.com\/en\/press-releases\/densitas-and-intelerad-forge-strategic-partnership-to-advance-breast-cancer-screening-with-innovative-ai-technology\/","title":{"rendered":"Densitas and Intelerad Forge Strategic Partnership to Advance Breast Cancer Screening with Innovative AI Technology"},"content":{"rendered":"\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tDownload PDF Version<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Raleigh, NC and HALIFAX, NS, October 17, 2023<\/strong> \u2013\u00a0 Densitas<\/a>\u00ae, a global leader in artificial intelligence solutions for breast cancer screening, announced a strategic partnership with Intelerad Medical Systems<\/a>\u00ae, a leading provider of medical imaging software and services. This partnership strengthens clinical decision-making, increases operational efficiencies, reduces costs, and improves mammography quality and mammography facility adherence with MQSA EQUIP standards.<\/p>

\u201cWe are excited about this strategic alliance that will instantaneously expand the reach of our intelliMammo\u00ae AI platform, extending it to 2,500 healthcare organizations that form Intelerad\u2019s install base. intelliMammo\u00ae is the nervous system of the breast imaging enterprise. Our advanced AI solutions for mammography<\/a> inject intelligence and insights into the clinical, administrative, and service delivery needs of breast cancer screening<\/a> providers,\u201d said Mo Abdolell<\/a>, CEO of Densitas.\u00a0<\/p>

Densitas intelliMammo\u00ae will provide actionable information to clinical care teams, managers, and administrators when and where it is needed by leveraging the international scale of Intelerad\u2019s IntelePACS\u00ae diagnostic imaging and PenRad\u00ae breast imaging reporting systems. This partnership will deliver a unique end-to-end solution for breast imaging facilities.<\/p>

\u201cWe are thrilled to announce our strategic partnership with Densitas\u00ae to offer intelliMammo\u00aeto healthcare providers, equipping them with sophisticated decision-making support and superior mammography quality improvement solutions,\u201d said Morris Panner<\/a>, President of Intelerad. \u201cWe are committed to supplying our customers with best-in-class solutions that not only ensure top-quality patient care but also enhance workflow efficiency. The introduction of intelliMammo\u00ae alongside our existing PenRad\u00ae breast imaging reporting system reinforces our strategic focus on women\u2019s health.\u201d<\/p>

intelliMammo\u00ae is a mammography enterprise software platform that comprises AI engines that generate breast density, mammography positioning quality, and breast cancer risk assessments that support enhanced workflows and continuous mammography quality improvement. Actionable insights from advanced analytics support better patient care, increased operational efficiencies, and strengthened compliance with FDA MQSA EQUIP and American College of Radiology (ACR) standards for mammography facilities.<\/p>

intelliMammo\u00ae densityAI\u2122 is a deep learning algorithm that generates standardized and automated breast density assessments from mammograms that align with the ACR BI-RADS\u00ae breast tissue composition density scale.<\/p>

intelliMammo\u00ae intelliPGMI\u2122 is an AI-based mammography positioning quality score that provides standardized and automated quality assessments of mammograms.<\/p>

intelliMammo\u00ae riskVue\u2122 delivers breast cancer risk assessments from select breast cancer risk models.<\/p>

About Densitas<\/b><\/p>

Densitas is a global leader in artificial intelligence solutions for breast cancer screening, focused on quality, safety, efficiency, and precision breast health. intelliMammo\u00ae\u00a0 supports hospitals and imaging centers delivering mammography services to improve efficiencies, meet FDA\/ACR compliance requirements, and support early breast cancer detection and treatment. For more information, visit www.densitashealth.com<\/a>.<\/p>

About Intelerad<\/b><\/p>

Intelerad is one of the leading providers of medical imaging software and service<\/a>s for the healthcare industry. Headquartered in Raleigh, NC, and Montreal, Quebec, Intelerad has over 900 employees located in offices across six countries. Nearly 2,500 healthcare organizations around the world rely on Intelerad products to manage patient data, helping them reduce time and workload while improving patient outcomes. Intelerad\u2019s award-winning enterprise imaging solutions have been recognized globally by KLAS, with Intelerad\u2019s Ambra Health ranked #1 in Image Exchange for eight consecutive years. To learn more, visit intelerad.com<\/a>.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

This partnership strengthens clinical decision-making, increases operational efficiencies, reduces costs, and improves mammography quality and mammography facility adherence with MQSA EQUIP standards.<\/p>\n","protected":false},"featured_media":1604,"template":"","class_list":["post-14944","press-release","type-press-release","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"\nDensitas and Intelerad Forge Strategic Partnership - Intelerad<\/title>\n<meta name=\"description\" content=\"Discover the Densitas and Intelerad partnership and how it enhances breast cancer screening with innovative AI technology.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.intelerad.com\/en\/press-releases\/densitas-and-intelerad-forge-strategic-partnership-to-advance-breast-cancer-screening-with-innovative-ai-technology\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Densitas and Intelerad Forge Strategic Partnership to Advance Breast Cancer Screening with Innovative AI Technology\" \/>\n<meta property=\"og:description\" content=\"Discover the Densitas and Intelerad partnership and how it enhances breast cancer screening with innovative AI technology.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.intelerad.com\/en\/press-releases\/densitas-and-intelerad-forge-strategic-partnership-to-advance-breast-cancer-screening-with-innovative-ai-technology\/\" \/>\n<meta property=\"og:site_name\" content=\"Intelerad\" \/>\n<meta property=\"article:modified_time\" content=\"2024-08-30T10:27:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.intelerad.com\/en\/wp-content\/uploads\/sites\/2\/2024\/03\/header_press-release.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1600\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.intelerad.com\/en\/press-releases\/densitas-and-intelerad-forge-strategic-partnership-to-advance-breast-cancer-screening-with-innovative-ai-technology\/\",\"url\":\"https:\/\/www.intelerad.com\/en\/press-releases\/densitas-and-intelerad-forge-strategic-partnership-to-advance-breast-cancer-screening-with-innovative-ai-technology\/\",\"name\":\"Densitas and Intelerad Forge Strategic Partnership - Intelerad\",\"isPartOf\":{\"@id\":\"https:\/\/www.intelerad.com\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.intelerad.com\/en\/press-releases\/densitas-and-intelerad-forge-strategic-partnership-to-advance-breast-cancer-screening-with-innovative-ai-technology\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.intelerad.com\/en\/press-releases\/densitas-and-intelerad-forge-strategic-partnership-to-advance-breast-cancer-screening-with-innovative-ai-technology\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.intelerad.com\/en\/wp-content\/uploads\/sites\/2\/2024\/03\/header_press-release.jpg\",\"datePublished\":\"2023-10-17T08:25:00+00:00\",\"dateModified\":\"2024-08-30T10:27:07+00:00\",\"description\":\"Discover the Densitas and Intelerad partnership and how it enhances breast cancer screening with innovative AI technology.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.intelerad.com\/en\/press-releases\/densitas-and-intelerad-forge-strategic-partnership-to-advance-breast-cancer-screening-with-innovative-ai-technology\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.intelerad.com\/en\/press-releases\/densitas-and-intelerad-forge-strategic-partnership-to-advance-breast-cancer-screening-with-innovative-ai-technology\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.intelerad.com\/en\/press-releases\/densitas-and-intelerad-forge-strategic-partnership-to-advance-breast-cancer-screening-with-innovative-ai-technology\/#primaryimage\",\"url\":\"https:\/\/www.intelerad.com\/en\/wp-content\/uploads\/sites\/2\/2024\/03\/header_press-release.jpg\",\"contentUrl\":\"https:\/\/www.intelerad.com\/en\/wp-content\/uploads\/sites\/2\/2024\/03\/header_press-release.jpg\",\"width\":1600,\"height\":800,\"caption\":\"A microphone standing in sharp focus before a blurred background of an audience, capturing the moment before a speech on accessible medical imaging begins.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.intelerad.com\/en\/press-releases\/densitas-and-intelerad-forge-strategic-partnership-to-advance-breast-cancer-screening-with-innovative-ai-technology\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.intelerad.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Densitas and Intelerad Forge Strategic Partnership to Advance Breast Cancer Screening with Innovative AI Technology\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.intelerad.com\/en\/#website\",\"url\":\"https:\/\/www.intelerad.com\/en\/\",\"name\":\"Intelerad\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.intelerad.com\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.intelerad.com\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.intelerad.com\/en\/#organization\",\"name\":\"Intelerad\",\"url\":\"https:\/\/www.intelerad.com\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.intelerad.com\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.intelerad.com\/en\/wp-content\/uploads\/sites\/2\/2024\/02\/logo.svg\",\"contentUrl\":\"https:\/\/www.intelerad.com\/en\/wp-content\/uploads\/sites\/2\/2024\/02\/logo.svg\",\"width\":128,\"height\":22,\"caption\":\"Intelerad\"},\"image\":{\"@id\":\"https:\/\/www.intelerad.com\/en\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Densitas and Intelerad Forge Strategic Partnership - Intelerad","description":"Discover the Densitas and Intelerad partnership and how it enhances breast cancer screening with innovative AI technology.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.intelerad.com\/en\/press-releases\/densitas-and-intelerad-forge-strategic-partnership-to-advance-breast-cancer-screening-with-innovative-ai-technology\/","og_locale":"en_US","og_type":"article","og_title":"Densitas and Intelerad Forge Strategic Partnership to Advance Breast Cancer Screening with Innovative AI Technology","og_description":"Discover the Densitas and Intelerad partnership and how it enhances breast cancer screening with innovative AI technology.","og_url":"https:\/\/www.intelerad.com\/en\/press-releases\/densitas-and-intelerad-forge-strategic-partnership-to-advance-breast-cancer-screening-with-innovative-ai-technology\/","og_site_name":"Intelerad","article_modified_time":"2024-08-30T10:27:07+00:00","og_image":[{"width":1600,"height":800,"url":"https:\/\/www.intelerad.com\/en\/wp-content\/uploads\/sites\/2\/2024\/03\/header_press-release.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.intelerad.com\/en\/press-releases\/densitas-and-intelerad-forge-strategic-partnership-to-advance-breast-cancer-screening-with-innovative-ai-technology\/","url":"https:\/\/www.intelerad.com\/en\/press-releases\/densitas-and-intelerad-forge-strategic-partnership-to-advance-breast-cancer-screening-with-innovative-ai-technology\/","name":"Densitas and Intelerad Forge Strategic Partnership - Intelerad","isPartOf":{"@id":"https:\/\/www.intelerad.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.intelerad.com\/en\/press-releases\/densitas-and-intelerad-forge-strategic-partnership-to-advance-breast-cancer-screening-with-innovative-ai-technology\/#primaryimage"},"image":{"@id":"https:\/\/www.intelerad.com\/en\/press-releases\/densitas-and-intelerad-forge-strategic-partnership-to-advance-breast-cancer-screening-with-innovative-ai-technology\/#primaryimage"},"thumbnailUrl":"https:\/\/www.intelerad.com\/en\/wp-content\/uploads\/sites\/2\/2024\/03\/header_press-release.jpg","datePublished":"2023-10-17T08:25:00+00:00","dateModified":"2024-08-30T10:27:07+00:00","description":"Discover the Densitas and Intelerad partnership and how it enhances breast cancer screening with innovative AI technology.","breadcrumb":{"@id":"https:\/\/www.intelerad.com\/en\/press-releases\/densitas-and-intelerad-forge-strategic-partnership-to-advance-breast-cancer-screening-with-innovative-ai-technology\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.intelerad.com\/en\/press-releases\/densitas-and-intelerad-forge-strategic-partnership-to-advance-breast-cancer-screening-with-innovative-ai-technology\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.intelerad.com\/en\/press-releases\/densitas-and-intelerad-forge-strategic-partnership-to-advance-breast-cancer-screening-with-innovative-ai-technology\/#primaryimage","url":"https:\/\/www.intelerad.com\/en\/wp-content\/uploads\/sites\/2\/2024\/03\/header_press-release.jpg","contentUrl":"https:\/\/www.intelerad.com\/en\/wp-content\/uploads\/sites\/2\/2024\/03\/header_press-release.jpg","width":1600,"height":800,"caption":"A microphone standing in sharp focus before a blurred background of an audience, capturing the moment before a speech on accessible medical imaging begins."},{"@type":"BreadcrumbList","@id":"https:\/\/www.intelerad.com\/en\/press-releases\/densitas-and-intelerad-forge-strategic-partnership-to-advance-breast-cancer-screening-with-innovative-ai-technology\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.intelerad.com\/en\/"},{"@type":"ListItem","position":2,"name":"Densitas and Intelerad Forge Strategic Partnership to Advance Breast Cancer Screening with Innovative AI Technology"}]},{"@type":"WebSite","@id":"https:\/\/www.intelerad.com\/en\/#website","url":"https:\/\/www.intelerad.com\/en\/","name":"Intelerad","description":"","publisher":{"@id":"https:\/\/www.intelerad.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.intelerad.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.intelerad.com\/en\/#organization","name":"Intelerad","url":"https:\/\/www.intelerad.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.intelerad.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.intelerad.com\/en\/wp-content\/uploads\/sites\/2\/2024\/02\/logo.svg","contentUrl":"https:\/\/www.intelerad.com\/en\/wp-content\/uploads\/sites\/2\/2024\/02\/logo.svg","width":128,"height":22,"caption":"Intelerad"},"image":{"@id":"https:\/\/www.intelerad.com\/en\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.intelerad.com\/en\/wp-json\/wp\/v2\/press-release\/14944","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.intelerad.com\/en\/wp-json\/wp\/v2\/press-release"}],"about":[{"href":"https:\/\/www.intelerad.com\/en\/wp-json\/wp\/v2\/types\/press-release"}],"version-history":[{"count":0,"href":"https:\/\/www.intelerad.com\/en\/wp-json\/wp\/v2\/press-release\/14944\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.intelerad.com\/en\/wp-json\/wp\/v2\/media\/1604"}],"wp:attachment":[{"href":"https:\/\/www.intelerad.com\/en\/wp-json\/wp\/v2\/media?parent=14944"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}